Jonušaitė I, Giedraitienė N, Kaubrys G, Kizlaitienė R. The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab. NS [Internet]. 2024 Mar. 20 [cited 2024 Jul. 17];27(Nr. 3 (97):127-35. Available from: https://www.journals.vu.lt/neurologijos_seminarai/article/view/34911